COMMUNIQUÉS West-GlobeNewswire

ObsEva SA to Present Nolasiban and Linzagolix Clinical Data at the ESHRE Annual Meeting June 23-26 in Vienna
21/06/2019
Geneva, Switzerland and Boston, MA – June 21, 2019 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious [...]
Bone Therapeutics SA: Information on the total number of voting rights and shares
21/06/2019
Regulated information Gosselies, Belgium, 21 June 2019, 7am CEST – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the bone cell therapy company addressing high unmet medical needs in orthopaedics and bone [...]
Bone Therapeutics SA : Information relative au nombre total de droits de vote et d’actions
21/06/2019
Information réglementée Gosselies, Belgique, le 21 juin 2019, 07h00 CEST - BONE THERAPEUTICS (code Euronext Bruxelles et Paris : BOTHE), société de thérapie cellulaire osseuse qui répond à d’importants besoins médicaux [...]
Axcella Health Reports First Quarter 2019 Financial Results and Provides Company Update
20/06/2019
Successfully completed initial public offering, raising $71.4 million in gross proceeds Presented data on AXA1665 and AXA1125 at two leading medical conferences Identified drug development path for AXA1665 following the [...]
Akcea and Ionis Announce Upcoming Data Presentations at the 2019 Peripheral Nerve Society Annual Meeting
20/06/2019
Multiple clinical presentations focus on the long-term clinical benefits of treatment with TEGSEDI® (inotersen) BOSTON and CARLSBAD, Calif., June 20, 2019 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ: AKCA), an [...]
ContraVir Pharmaceuticals Receives Positive FDA Response to CRV431 Pre-IND Package for NASH
20/06/2019
Feedback Supports Preclinical and Clinical Development Plan and Planned IND Filing for CRV431 for NASH EDISON, N.J., June 20, 2019 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV), a biopharmaceutical [...]
Geron Appoints Vice President, Human Resources
20/06/2019
MENLO PARK, Calif., June 20, 2019 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today announced the appointment of Shannon Odam as Vice President, Human Resources. Ms. Odam joins other recently recruited senior [...]
IBRI in license agreement for access to Lilly’s Fab Phage Display Library
20/06/2019
Will speed the discovery and validation of new antibodies to improve human health INDIANAPOLIS, June 20, 2019 (GLOBE NEWSWIRE) -- The Indiana Biosciences Research Institute (IBRI) today announced it has entered into a [...]
Selecta Biosciences Announces Appointment of Scott D. Myers to Board of Directors
20/06/2019
WATERTOWN, Mass., June 20, 2019 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ: SELB), a clinical-stage biotechnology company focused on unlocking the full potential of biologic therapies based on its immune [...]
Galapagos increases share capital through warrant exercises
20/06/2019
Mechelen, Belgium; 20 June 2019, 22.01 CET; regulated information - Galapagos NV (Euronext & NASDAQ: GLPG) announces a share capital increase arising from warrant exercises. Galapagos issued 208,310 new ordinary [...]
Valneva Announces Mutual Agreement with GSK to End Strategic Alliance Agreement; Regains Control of R&D
20/06/2019
Valneva Announces Mutual Agreement with GSK to End Strategic Alliance Agreement; Regains Control of R&D Investor/analyst conference call tomorrow at 09:30 CEST Saint Herblain (France), June 20, 2019 – Valneva SE (“ [...]
Valneva annonce un accord avec GSK mettant fin à l’alliance stratégique entre les deux sociétés. Valneva reprend le contrôle de sa R&D
20/06/2019
Valneva annonce un accord avec GSK mettant fin à l’alliance stratégique entre les deux sociétés. Valneva reprend le contrôle de sa R&D Conférence téléphonique pour les investisseurs et analystes demain à 09:30 CEST [...]
Esperoct® (turoctocog alfa pegol, N8-GP) approved in the EU
20/06/2019
Bagsværd, Denmark, 20 June 2019 – Novo Nordisk today announced that the European Commission has granted marketing authorisation for Esperoct ® for the treatment of adolescents (≥12 years of age) and adults with [...]
Continuation of “Atalante 1” Phase 3 Clinical Trial of Tedopi® in NSCLC Patients Post Checkpoint Inhibitor Failure Following IDMC Recommendation
20/06/2019
NANTES, France, June 20, 2019 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics (ISIN: FR0012127173; Mnémo: OSE) today announced that, after reviewing global study data, the Independent Data Monitoring Committee (IDMC) saw no [...]
Thousands of Diabetic Foot Ulcer Patients Could Benefit From Topical Oxygen Therapy With Updated Treatment Pathway
20/06/2019
Expert Panel Report recommends updated algorithm for the use of topical oxygen therapy which could help the estimated 169,000 UK patients with diabetic foot ulcers 1 Topical oxygen therapy is recommended as an adjunct [...]
SEC Investigation of Misonix, Inc. Ends With No Action
20/06/2019
FARMINGDALE, N.Y., June 20, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, today announced that [...]
Kane Biotech and Nestlé Reach Settlement
20/06/2019
WINNIPEG, Manitoba, June 20, 2019 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE), (the “Corporation” or “Kane Biotech”), a biotechnology company engaged in the research, development and commercialization of [...]
Ritter Pharmaceuticals Provides Phase 3 Liberatus Clinical Trial and Regulatory Update
20/06/2019
LOS ANGELES, June 20, 2019 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a developer of innovative therapeutic products that modulate the gut microbiome to [...]
UPDATE - Sharps Compliance Releases New Solution Offering for the Safe and Compliant Cleanup of Spilled Hazardous Drugs
20/06/2019
Spill Kit in Compliance with New USP Rules HOUSTON, June 20, 2019 (GLOBE NEWSWIRE) -- Sharps Compliance Corp. (Nasdaq: SMED), a nationwide provider of management services for medical, pharmaceutical, and hazardous [...]

Pages